Works matching IS 13657852 AND DT 1999 AND VI 2 AND IP 2

Results: 13

Immunohistochemical BCL-2 and Ki-67 expression predict survival in prostate cancer patients followed expectantly.

Published in:

Prostate Cancer & Prostatic Diseases, 1999, v. 2, n. 2, p. 106, doi. 10.1038/sj.pcan.4500285

By:

Borre, M;
Srausbol-Gron, B;
Nostrom, B;
Overgaard, J

Publication type:

Article

Characterization and processing of prostate specific antigen (hK3) and human glandular kallikrein (hK2) secreted by LNCaP cells.

Published in:

Prostate Cancer & Prostatic Diseases, 1999, v. 2, n. 2, p. 91

By:

Väisänen, V;
Lövgren, J;
Hellman, J;
Piironen, T;
Lilja, H;
Pettersson, K

Publication type:

Article

Strategies for the chemoprevention of prostate cancer, Brussels, Belgium, October 30–31, 1998.

Published in:

Prostate Cancer & Prostatic Diseases, 1999, v. 2, n. 2, p. 59, doi. 10.1038/sj.pcan.4500290

By:

Kirby, R S

Publication type:

Article

Medical management of BPH: Where are we going?

Published in:

Prostate Cancer & Prostatic Diseases, 1999, v. 2, n. 2, p. 62, doi. 10.1038/sj.pcan.4500291

By:

Kirby, R S

Publication type:

Article

High energy transurethral thermotherapy in the treatment of benign prostatic hyperplasia: criteria to predict treatment outcome.

Published in:

Prostate Cancer & Prostatic Diseases, 1999, v. 2, n. 2, p. 98, doi. 10.1038/sj.pcan.4500293

By:

d’Ancona, F C H;
Francisca, E A E;
Hendriks, J C M;
Debruyne, F M J;
de la Rosette, J J M C H

Publication type:

Article

Antibiotic prophylaxis for prostate biopsy: benefits and costs.

Published in:

Prostate Cancer & Prostatic Diseases, 1999, v. 2, n. 2, p. 88, doi. 10.1038/sj.pcan.4500294

By:

Larsson, P;
Norming, U;
Törnblom, M;
Gustafsson, O

Publication type:

Article

Insulin-like Growth Factor (IGF) Network and Prostate Pathologies.

Published in:

Prostate Cancer & Prostatic Diseases, 1999, v. 2, n. 2, p. 66, doi. 10.1038/sj.pcan.4500295

By:

Tatoud, R

Publication type:

Article

Pathologic progression of autochthonous prostate cancer in the TRAMP model.

Published in:

Prostate Cancer & Prostatic Diseases, 1999, v. 2, n. 2, p. 70, doi. 10.1038/sj.pcan.4500296

By:

Gingrich, J R;
Barrios, R J;
Foster, B A;
Greenberg, N M

Publication type:

Article

Characterization of the FGF axis and identification of a novel FGFR1iiic isoform during prostate cancer progression in the TRAMP model.

Published in:

Prostate Cancer & Prostatic Diseases, 1999, v. 2, n. 2, p. 76, doi. 10.1038/sj.pcan.4500297

By:

Foster, B A;
Kaplan, P J;
Greenberg, N M

Publication type:

Article

What’s hot in the prostate?Think tank workshop on localised prostate cancer.

Published in:

Prostate Cancer & Prostatic Diseases, 1999, v. 2, n. 2, p. 55, doi. 10.1038/sj.pcan.4500298

By:

Belldegrun, Edited by Arie

Publication type:

Article

Estramustine in combination with vinblastine and mitomycin-C for patients with progressive androgen independent adenocarcinoma of the prostate.

Published in:

Prostate Cancer & Prostatic Diseases, 1999, v. 2, n. 2, p. 83, doi. 10.1038/sj.pcan.4500299

By:

Amato, R J;
Bui, C;
Logothetis, C J

Publication type:

Article

Are we making an impact on prostate cancer?

Published in:

Prostate Cancer & Prostatic Diseases, 1999, v. 2, n. 2, p. 60, doi. 10.1038/sj.pcan.4500300

By:

Figg, W D;
Blumenfeld, J R

Publication type:

Article

Editorial.

Published in:

Prostate Cancer & Prostatic Diseases, 1999, v. 2, n. 2, p. 58, doi. 10.1038/sj.pcan.4500301

By:

Kirby, R;
Scher, H;
Brawer, M

Publication type:

Article